SAN DIEGO--(BUSINESS WIRE)--Orexigen™ Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders including obesity, today announced that Gary Tollefson, M.D., Ph.D., Orexigen’s President and CEO, will present at the upcoming BioCentury NewsMakers in the Biotech Industry Conference on Thursday, September 6 at 11:25 a.m. EDT.
